Search

everythinglearnresearchcommunity

for

Search:↓

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Skin problems are very common in people with end-stage kidney disease.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Photothermal hydrogels are promising for infection control and tissue repair, and combining them with other treatments could improve results and lower costs.

Biotin supplements are not proven to improve hair or nails and may interfere with medical tests.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Vitamin D receptor is crucial for starting hair growth after birth.

FOXN1 gene variants cause low T cells and immune issues from birth.

Oral retinoids can cause side effects ranging from mild to severe, including birth defects, and require careful monitoring and contraception.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

A boy with severe Vitamin D-resistant rickets did not respond to treatment and lacked a common symptom, suggesting a need for alternative treatments.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

New alopecia treatments aim for better results and fewer side effects.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Some alternative treatments for hair loss might work, but more research is needed.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Isotretinoin effectively reduces acne but causes dry skin, higher skin pH, more redness, and hair loss.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Fullerene nanomaterials help hair grow faster and increase hair follicles.

Fibroblasts, cells usually linked to tissue repair, also help regenerate various organs and their ability decreases with age. Turning adult fibroblasts back to a younger state could be a new treatment approach.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.